Patents Assigned to Cellenkos, Inc.
  • Patent number: 12692478
    Abstract: Provided herein are populations of enriched ex vivo expanded umbilical cord blood-derived regulatory T cells. Also provided are methods of making and using the same.
    Type: Grant
    Filed: March 25, 2022
    Date of Patent: July 28, 2026
    Assignee: Cellenkos, Inc.
    Inventor: Simrit Parmar
  • Patent number: 12472182
    Abstract: Provided herein are populations of ex vivo expanded umbilical cord blood-derived regulatory T cells. Also provided are methods of making and using the same.
    Type: Grant
    Filed: September 25, 2020
    Date of Patent: November 18, 2025
    Assignee: Cellenkos, Inc.
    Inventor: Simrit Parmar